梯瓦制药

关于 Teva Pharmaceutical Industries

Teva 制药 Industries 有限公司. 从事 the 开发, 生产, and 销售 of medicines. It 运营 through the following geographical 部分: United States, Europe, and International Markets. The United States 部分 专注于 therapeutic area of central nervous system (CNS) portfolio, and is 参与 the 分销 业务 of generic, biosimilar and medicines, and over-the-counter (OTC) 制药 产品 from the firm and third-party manufacturers to independent 零售 pharmacies, pharmacy 零售 chains, hospitals, and physician offices in the United States. The Europe 部分 提供 OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets 部分 提供 its 产品 to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was 成立 in 1901 and is 总部位于 in Tel Aviv, Israel.

成立时间

1901

首席执行官

Mr. Richard D. Francis

员工人数

33,950

总部地址

Tel Aviv, Tel Aviv, Israel

财年结束日

12-31

官方网站

tevapharm.com

公司概况

交易所

US

股票代码

TEVA

市值排名

#471

上市日期

1970-01-01

市值

48.40B

流通市值

45.23B

总股数

1.17B

流通股数

1.09B

行业与主题板块

浏览全部行业与主题板块